Kraig Biocraft Laboratories, Inc. (KBLB)
- Previous Close
0.0960 - Open
0.0950 - Bid --
- Ask --
- Day's Range
0.0917 - 0.0950 - 52 Week Range
0.0300 - 0.1500 - Volume
78,460 - Avg. Volume
1,661,309 - Market Cap (intraday)
96.932M - Beta (5Y Monthly) 0.33
- PE Ratio (TTM)
-- - EPS (TTM)
-0.0000 - Earnings Date May 10, 2024 - May 14, 2024
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
Kraig Biocraft Laboratories, Inc. engages in developing protein-based fibers using recombinant DNA technology for commercial applications in the technical textile and specialty fiber industries in the United States. Its primary proprietary fiber technology includes natural and engineered variants of spider silk produced in domesticated mulberry silkworms, as well as uses genetically engineered silkworms that produce spider silk proteins to create its recombinant spider silk. The company's products are used in military and police, and defense applications for ballistic protection; industrial applications, including critical cables and abrasion/impact resistant components; safety equipment; and composite materials for the aero-space industry. Its products are also used in various markets, such as medical textiles, geotextiles, defense and military textiles, safe and protective clothing, filtration textiles, composites with textile structure, and functional and sportive textiles, as well as textiles used in buildings and transportation. Kraig Biocraft Laboratories, Inc. was incorporated in 2006 and is headquartered in Ann Arbor, Michigan.
www.kraiglabs.com37
Full Time Employees
December 31
Fiscal Year Ends
Sector
Industry
Recent News: KBLB
Performance Overview: KBLB
Trailing total returns as of 4/25/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: KBLB
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: KBLB
Valuation Measures
Market Cap
99.68M
Enterprise Value
104.10M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
--
Price/Book (mrq)
--
Enterprise Value/Revenue
--
Enterprise Value/EBITDA
-41.35
Financial Highlights
Profitability and Income Statement
Profit Margin
0.00%
Return on Assets (ttm)
-41.88%
Return on Equity (ttm)
--
Revenue (ttm)
--
Net Income Avi to Common (ttm)
-3.03M
Diluted EPS (ttm)
-0.0000
Balance Sheet and Cash Flow
Total Cash (mrq)
2.55M
Total Debt/Equity (mrq)
--
Levered Free Cash Flow (ttm)
-280.91k
Company Insights: KBLB
KBLB does not have Company Insights